Abstract
BackgroundPresepsin (soluble CD14 subtype) is a newly recognized biomarker of sepsis. Recently it has been reported that presepsin levels are elevated in patients with systemic lupus erythematosus (SLE) without infection,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
